A population pharmacokinetic model for vancomycin in pediatric patients and its predictive value in a naive population

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 2, 2000, Pages 278-282

  Lamarre, Patrice ^a,b   Lebel, Denis ^b   Ducharme, Murray P ^a,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c Pharmacokin and Pharmacodynamics   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ACCURACY; ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; CHILD; COMPARTMENT MODEL; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; FEMALE; HUMAN; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEWBORN; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; VALIDATION PROCESS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; VANCOMYCIN;

EID: 0033958126     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.2.278-282.2000     Document Type: Article

References (16)

1. Boyle, J. F., S. A. Soumakis, and A. L. Rendo. 1993. Epidemiologic analyses and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J. Clin. Microbiol. 31:1280-1285.
2. Cantu, T., N. Yamanaka-Yuen, and P. S. Lietman. 1994. Serum vancomycin concentrations: reappraisal of their clinical value. Clin. Infect. Dis. 8:533-543.
3. Centers for Disease Control and Prevention. 1993. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. Morbid. Mortal. Weekly Rep. 42:597-599.
4. Costeff, H. 1966. A simple empirical formula for calculating approximate surface area in children. Arch. Dis. Child. 41:681-683.
5. Cunha, B. A., and A. M. Ortega. 1995. Antibiotic failure. Med. Clin. N. Am. 79:663-671.
6. D'Argenio, D. Z., C. C. Peck, and J. H. Rodman. 1992. Analysis of pharmacokinetic data for individualizing drug dosage regimens, p. 3-1-3-31. In W. E. Evans, J. J. Schentag, and W. J. Jusko (ed.), Applied pharmacokinetics, 3rd ed. Applied Therapeutics, Vancouver, Wash.
7. Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, 2nd ed. Marcel Dekker, Inc., New York, N.Y.
8. Hiramatsu, K., H. Hanaki, and T. Ino. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-136.
9. Lisby-Sutch, S. M., and M. C. Nahata. 1988. Dosage guidelines for the use of vancomycin based on its pharmacokinetics in infants. Eur. J. Clin. Pharmacol. 35:637-642.
10. Miles, M. V., L. Li, H. Lakkis, and J. Youngblood. 1997. Special considerations for monitoring vancomycin concentrations in pediatric patients. Ther. Drug Monit. 19:265-270.
11. Rodvold, K. A., J. A. Everett, and R. D. Pryka. 1997. Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children. Clin. Pharmacokinet. 33:32-51.
12. Schaad, U. B., G. H. McCracken, and J. D. Nelson. 1980. Clinical pharmacology and efficacy of vancomycin in pediatric patients. J. Pediatr. 96:119-126.
13. Schwartz, G. J., G. B. Haycock, C. M. Edelmann, Jr., and A. Spitzer. 1976. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259-263.
14. Seay, R. E., R. C. Brundage, and P. D. Jensen. 1994. Population pharmacokinetic of vancomycin in neonates. Clin. Pharmacol. Ther. 56:169-175.
15. Sheiner, L. B., and S. L. Beal. 1981. Some suggestions for measuring predictive performance. J. Pharmacokinet. Biopharm. 4:503-512.
16. Taketomo, C. K., J. H. Hodding, and D. M. Kraus. 1996. Pediatric dosage handbook, p. 74-75. Lexi-Comp, Inc., Hudson, Ohio.